ABC | Volume 115, Nº1, Julho 2020

Artigo Original Derakhshanian et al. Quercetina melhora a dislipidemia induzida por glicocorticóides Arq Bras Cardiol. 2020; 115(1):102-108 Conclusão A administração de quercetina, em doses de 50 e 150 mg/kg, pode reverter os efeitos indesejáveis de altas doses de glicocorticoides no perfil lipídico de ratos e pode ser considerada para terapia combinada com GCs para minimizar a dislipidemia resultante. Contribuição dos autores Concepção e desenho da pesquisa: DerakhshanianH, Djalali M, Djazayery A, Javanbakht MH, Dehpour AR; Obtenção de dados: Derakhshanian H, Zarei M, Eslamian G; Análise e interpretaçãodos dados: DerakhshanianH, JavanbakhtMH, Zarei M, EslamianG,Mirhashemi SS; Análise estatística: Derakhshanian H, Mirhashemi SS; Obtenção de financiamento: Derakhshanian H,DjalaliM,DjazayeryA; Redaçãodomanuscrito:Derakhshanian H; Revisão crítica do manuscrito quanto ao conteúdo intelectual importante: DerakhshanianH, DjalaliM, Djazayery A, Javanbakht MH, Hekmatdoost A, Dehpour AR. Potencial conflito de interesses Declaro não haver conflito de interesses pertinentes. Fontes de financiamento Este artigo é financiado pelo Tehran University of Medical Sciences. Vinculação acadêmica Este artigo é parte de dissertação de Mestrado de Hoda Derakhshanian pela Tehran University of Medical Sciences. Aprovação ética e consentimento informado Este estudo foi aprovado pelo Comitê de Ética do Tehran University of Medical Sciences sob o número de protocolo 11157. Todos os procedimentos envolvidos nesse estudo estão de acordo com a Declaração de Helsinki de 1975, atualizada em 2013. 1. Arafah BM. Pharmacology of glucocorticoids. In: Levine A, editor. Adrenal disorders. Contemporary endocrinology. Cham: Humana Press; 2018. p. 67-81. 2. Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol. 2010;49(3):239-48. 3. Staels B, van Tol A, Chan L, Verhoeven G, Auwerx J. Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoproteinmRNA levels in rats. Arterioscler Thromb. 1991;11(3):760-9. 4. Yadav A, Jahan A, Yadav TP, Sachdev N, Chitkara A, Asare R. Effect of glucocorticoids on serum lipid profile and endothelial function and arterial wall mechanics. Indian J Pediatr. 2013;80(12):1007-14. 5. Bentz AB. A Review of quercetin: chemistry, antioxident properties, and bioavailability. J Young Investig. 2009 apr. 6. Shah PM, Priya VV, Gayathri R. Quercetin-a flavonoid: a systematic review. J Pharm Sci Res. 2016;8(8):878-80. 7. D’Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia. 2015 Oct;106:256-71. 8. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167. 9. David AVA, Arulmoli R, Parasuraman S. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev. 2016;10(20):84-9. 10. Ginwala R, Bhavsar R, ChigbuDI, Jain P, Khan ZK. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti- inflammatory activity of apigenin. Antioxidants. 2019;8(2):pii:E35. 11. Javanbakht MH, Djalali M, Daneshpazhooh M, Zarei M, Eshraghian MR, Derakhshanian H, et al. Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgaris. Clin Exp Dermatol. 2015;40(3):313-7. 12. Santhakumar AB, Battino M, Alvarez-Suarez JM. Dietary polyphenols: structures, bioavailability and protective effects against atherosclerosis. Food Chem Toxicol. 2018 Mar;113:49-65. 13. Sahebkar A. Effects of quercetin supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2017;57(4):666-76. 14. National ResearchCouncil. Guide for the care and use of laboratory animals. 8th ed. Washington (DC): National Academies Press; 2011. 15. Hazra A, Pyszczynski NA, DuBois DC, Almon RR, Jusko WJ. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res. 2008;25(4):769-80. 16. Green C, Knight J, Precious S, Simpkin S. Ketamine alone and combined with diazepamor xylazine in laboratory animals: a 10 year experience. Lab Anim. 1981;15(2):163-70. 17. FriedewaldWT, Levy RI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. 18. de Vrie JH, Janssen PL, Hollman PC, van Staveren WA, Katan MB. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett. 1997;114(1-2):141-4. 19. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27-31. 20. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol. 2000;16(4):505-11. 21. Van DeWier B, Koek GH, Bast A, Haenen GR. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Crit Rev Food Sci Nutr. 2017;57(4):834-55. 22. Seiva FR, Chuffa LG, Braga CP, Amorim JP, Fernandes AA. Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatallymonosodiumglutamate-inducedmetabolic alterations. Food Chem Toxicol. 2012;50(10):3556-61. 23. Peluso MR. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med. 2006;231(8):1287-99. 24. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity. 2008;16(9):2081-7. 25. Mbikay M, Mayne J, Sirois F, Fedoryak O, Raymond A, Noad J, et al. Mice fed a high-cholesterol diet supplemented with quercetin-3-glucoside show attenuated hyperlipidemia and hyperinsulinemia associated with differential regulation of PCSK9 and LDLR in their liver and pancreas. Mol Nutr Food Res. 2018;62(9):1700729. 26. Ishisaka A, Ichikawa S, Sakakibara H, Piskula MK, Nakamura T, Kato Y, et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med. 2011;51(7):1329-36. Referências 107